Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States.

Yong M, Schwartz SM, Atkinson C, Makar KW, Thomas SS, Newton KM, Aiello Bowles EJ, Holt VL, Leisenring WM, Lampe JW.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):537-46. doi: 10.1158/1055-9965.EPI-09-0898.

2.

Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk.

McGrath M, Lepine J, Lee IM, Villeneuve L, Buring J, Guillemette C, De Vivo I.

Pharmacogenet Genomics. 2009 Mar;19(3):239-43. doi: 10.1097/FPC.0b013e328323f66c.

3.

Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes.

Schulze JJ, Lorentzon M, Ohlsson C, Lundmark J, Roh HK, Rane A, Ekström L.

Pharmacogenet Genomics. 2008 Jun;18(6):477-85. doi: 10.1097/FPC.0b013e3282fad38a.

PMID:
18496127
4.

Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines.

Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, Yokoi T.

Drug Metab Dispos. 2008 Aug;36(8):1461-4. doi: 10.1124/dmd.108.021428. Epub 2008 May 14.

5.

Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States.

Atkinson C, Newton KM, Stanczyk FZ, Westerlind KC, Li L, Lampe JW.

Cancer Causes Control. 2008 Dec;19(10):1085-93. doi: 10.1007/s10552-008-9172-3. Epub 2008 May 14.

PMID:
18478336
6.

Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues.

Starlard-Davenport A, Lyn-Cook B, Radominska-Pandya A.

Steroids. 2008 Jul;73(6):611-20. doi: 10.1016/j.steroids.2008.01.019. Epub 2008 Feb 3. Erratum in: Steroids. 2009 Jun;74(6):548-9.

8.

A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3.

Caillier B, Lépine J, Tojcic J, Ménard V, Perusse L, Bélanger A, Barbier O, Guillemette C.

Pharmacogenet Genomics. 2007 Jul;17(7):481-95.

PMID:
17558304
9.

Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.

Park J, Chen L, Ratnashinge L, Sellers TA, Tanner JP, Lee JH, Dossett N, Lang N, Kadlubar FF, Ambrosone CB, Zachariah B, Heysek RV, Patterson S, Pow-Sang J.

Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1473-8.

10.

Genetic variability, haplotypes, and htSNPs for exons 1 at the human UGT1A locus.

Thomas SS, Li SS, Lampe JW, Potter JD, Bigler J.

Hum Mutat. 2006 Jul;27(7):717.

PMID:
16786511
11.

Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.

Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):972-8.

12.
13.

Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism.

Jakobsson J, Ekström L, Inotsume N, Garle M, Lorentzon M, Ohlsson C, Roh HK, Carlström K, Rane A.

J Clin Endocrinol Metab. 2006 Feb;91(2):687-93. Epub 2005 Dec 6.

PMID:
16332934
14.

Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes.

Lazarus P, Zheng Y, Runkle EA, Muscat JE, Wiener D.

Pharmacogenet Genomics. 2005 Nov;15(11):769-78.

PMID:
16220109
15.

Common genetic polymorphisms in the 5'-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity.

Ning B, Nowell S, Sweeney C, Ambrosone CB, Williams S, Miao X, Liang G, Lin D, Stone A, Ratnasinghe DL, Manjanatha M, Lang NP, Kadlubar FF.

Pharmacogenet Genomics. 2005 Jul;15(7):465-73.

PMID:
15970794
16.

Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15.

Wilson W 3rd, Pardo-Manuel de Villena F, Lyn-Cook BD, Chatterjee PK, Bell TA, Detwiler DA, Gilmore RC, Valladeras IC, Wright CC, Threadgill DW, Grant DJ.

Genomics. 2004 Oct;84(4):707-14.

PMID:
15475248
17.

Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium.

Lépine J, Bernard O, Plante M, Têtu B, Pelletier G, Labrie F, Bélanger A, Guillemette C.

J Clin Endocrinol Metab. 2004 Oct;89(10):5222-32.

PMID:
15472229
18.

UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients.

Sparks R, Ulrich CM, Bigler J, Tworoger SS, Yasui Y, Rajan KB, Porter P, Stanczyk FZ, Ballard-Barbash R, Yuan X, Lin MG, McVarish L, Aiello EJ, McTiernan A.

Breast Cancer Res. 2004;6(5):R488-98. Epub 2004 Jun 29.

19.

Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer.

Park J, Chen L, Shade K, Lazarus P, Seigne J, Patterson S, Helal M, Pow-Sang J.

J Urol. 2004 Jun;171(6 Pt 1):2484-8.

PMID:
15126881
20.

Evaluating organized breast cancer screening implementation: the prevention of late-stage disease?

Taplin SH, Ichikawa L, Buist DS, Seger D, White E.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):225-34.

Supplemental Content

Support Center